Biotechnology
Untangling the enigma of PCOS and its distressing impacts in 12 per cent of women
ADELAIDE, Australia, Sept. 7, 2023 /PRNewswire/ -- Psychological issues including anxiety, depression and negative body image are adding to the physical burden of polycystic ovary syndrome (PCOS), a hormonal disorder that affects 12 per cent of women globally. International research has reveal...
2023-09-07 09:36
1906
Metabolon Achieves "Great Place To Work"® Certification
Independent survey validates that Metabolon employees are highly invested in the company's mission, growth, and technology MORRISVILLE, N.C., Sept. 6, 2023 /PRNewswire/ -- Metabolon, Inc. is proud to be certified by Great Place To Work®. The prestigious certification is based entirely on curren...
2023-09-06 19:57
1408
Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule
BRIDGEWATER, N.J. and BENGALURU, India, Sept. 6, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the Company has completed the integration of the acquired biosimilars business from Viatris inNorth America (United St...
2023-09-06 19:00
1432
Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B
BRII-179 (VBI-2601) as an add-on therapy to standard of care PEG-IFNα increases HBsAg loss rate at the end of treatment and 12 weeks follow up Significantly increased HBsAg seroconversion rate is strongly associated with BRII-179 treatment and correlates with the increased rate of HBsAg loss Saf...
2023-09-06 18:45
2047
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM
MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held inVienna from 9...
2023-09-06 14:18
1422
Zimmer Biomet India Launches Zimmer Biomet on Wheels Campaign
NEW DELHI, Sept. 6, 2023 /PRNewswire/ -- Zimmer Biomet India today announced the launch of the Zimmer Biomet on Wheels campaign, a mobile vehicle housing the company's innovative products and solutions, including Knee, Hips, Shoulder, and Sports Medicine product portfolios that leverage data, ana...
2023-09-06 11:30
1873
MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study
GENEVA, Sept. 6, 2023 /PRNewswire/ -- The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where ...
2023-09-06 08:00
1536
YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference
GAITHERSBURG, Md., Sept. 5, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious di...
2023-09-05 20:30
1452
European Wellness and Heidelberg University Revolutionize Down Syndrome Research, Moving into Neurodevelopmental and Neurodegenerative Studies
HEIDELBERG, Germany, Sept. 5, 2023 /PRNewswire/ -- A ground-breaking research collaboration between European Wellness Biomedical Group (EWBG), through its subsidiaries European Wellness Academy (EWA) and Baden R&D Laboratories (Baden), and Heidelberg's Institute of Anatomy and Cell Biology has yi...
2023-09-05 14:06
1757
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform * ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data * ACM is in partnering d...
2023-09-05 14:00
1437
Ascletis to Participate in the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference
HANGZHOU and SHAOXING, China, Sept. 5, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will participate in the upcoming Morgan Stanley 21st Annual Global Healthcare Conference.John Gargiulo, Chief Business Officer of Ascletis, will join the fireside chat...
2023-09-05 08:10
1686
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature
* The program is a part of the Seegene OneSystemTM business aimed at creating a 'world free from all diseases' * Collaborating with clinical researchers worldwide, Seegene will share its technologies and enable researchers to develop syndromic qPCR assays SEOUL, South Korea, Sept. 4, 2023 /PR...
2023-09-04 21:00
2031
National University Health System Launches World's First Public Hospital's Healthy Longevity Clinic at Alexandra Hospital
SINGAPORE, Sept. 2, 2023 /PRNewswire/ -- The National University Health System
(NUHS), NUS Yong Loo Lin School of Medicine andAlexandra Hospital (AH
2023-09-02 13:00
3083
Sirnaomics Announces Successful Phase I Clinical Study of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors
* Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. * All cohorts demonstrated a strong safety profile with no dose-limiting toxicity noted for any dosing cohort and the treated patients exhibited encouraging...
2023-08-31 11:30
4308
Broncus Medical (02216.HK) Announces Interim Results for 2023
Product sales in China for interim FY2023 increased of 114% compared to the same period in 2022, while product commercialization is steadily advancing. HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ -- On August 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis and t...
2023-08-30 23:49
5849
The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare
* Japanese Ministry of Health, Labor and Welfare grants Orphan Drug Designation to tagraxofusp for blastic plasmacytoid dendritic cell neoplasm (BPDCN) FLORENCE, Italy and NEW YORK, Aug. 30, 2023 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagno...
2023-08-30 23:15
1951
European Society of Cardiology Congress: Traditional Chinese Medicine Qili Qiangxin significantly reduces the risk of cardiovascular death and re-hospitalization due to heart failure
AMSTERDAM, Aug. 30, 2023 /PRNewswire/ -- The latest study indicates that adding TCM Qili Qiangxin Capsules (developed and produced by Yiling Pharmaceutical) to the standard of care for heart failure can significantly reduce the risk of re-hospitalization due to worsening heart failure and cardio...
2023-08-30 20:11
1327
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023
* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be presented by Cerecin's Chief Medical Officer, Dr. Marc Cantillon on Sunday 2nd September at 2pm (GMT+1). * The Cerecin team will be accompanied by PharmaVentures, who will be supporting Cerecin's ...
2023-08-30 00:04
1527
Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability
Highlights of the Interim Results as of June 30, 2023: * Revenue reached RMB1,142.2 million, representing a year-on-year increase of approximately 3.0% * Gross profit amounted to RMB406.0 million, representing a year-on-year increase of approximately 17.7% * Adjusted Non-IFRS net profit amo...
2023-08-29 22:38
2250
A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television
* Miss Hong Kong Pageant 2023 winner is Hilary Chong (no. 15) HONG KONG, Aug. 29, 2023 /PRNewswire/ -- In a move that had never been seen before, marrying beauty with science, the Miss Hong Kong Pageant 2023, which justaired on TVB, had set out to revolutionize the industry by partnering with C...
2023-08-29 12:46
1762
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 318 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 301 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 273 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8601
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
7969
Where does China's production capacity come from?
2024-05-10 12:01
7807
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4977